Quddus M Ruhul, Sung C James, Eklund Claire M, Reilly Mary E, Steinhoff Margaret M
Department of Pathology, Women and Infants Hospital and Brown Medical School, Providence, Rhode Island 02905, USA.
Diagn Cytopathol. 2004 Apr;30(4):240-2. doi: 10.1002/dc.10304.
The 2001 Bethesda system (TBS 2001) eliminated the "satisfactory but limited by" category, benign cellular changes (BCC), and the designations "favor benign" (ASC-B) and "favor low grade" (ASC-L) for atypical squamous cells. We compared the unsatisfactory rate and atypical squamous cells:squamous intraepithelial lesions (ASC:SIL) ratio pre- and postimplementation of TBS 2001 to see if there was an increase in unsatisfactory specimens, ASC rate, and altered ASC:SIL ratio. Pap Tests (569,726) reviewed at the Cytopathology Laboratory of Women and Infants Hospital from 1998-2002 were included. TBS 1991 terminology was used through December 31, 2001. Conversion to TBS 2001 took place on January 1, 2002. The average ASC:SIL ratios pre- and postimplementation of TBS 2001 were 1.52:1 and 1.42:1, respectively. The rates of unsatisfactory specimens and ASC remained unchanged. Conversion to TBS 2001 did not adversely affect the ASC:SIL ratio or the detection rates of abnormalities of Pap tests.
2001年贝塞斯达系统（TBS 2001）取消了“满意但有局限”类别、良性细胞改变（BCC）以及非典型鳞状细胞的“倾向良性”（ASC-B）和“倾向低级别”（ASC-L）的标注。我们比较了TBS 2001实施前后不满意率以及非典型鳞状细胞与鳞状上皮内病变的比例（ASC:SIL），以观察不满意标本数量、ASC率以及ASC:SIL比例是否发生变化。纳入了1998年至2002年在妇女和婴儿医院细胞病理学实验室复查的569,726份巴氏涂片。在2001年12月31日前使用TBS 1991术语。2002年1月1日开始采用TBS 2001。TBS 2001实施前后的平均ASC:SIL比例分别为1.52:1和1.42:1。不满意标本率和ASC率保持不变。采用TBS 2001对ASC:SIL比例或巴氏涂片异常检测率没有不利影响。
